Big Pain Coming…

Quote







anonymous said:
Maybe for once we will start being realistic about outlook. Merck assumes best case and seldom plan for worst case. Was it realistic to expect all untapped markets to embrace a vaccine that could go against certain cultural expectations and religious principals?
Click to expand...
Yep, agree. We strung investors along with the Guardasil issue in China, paying for it now. Stock down 10 points, lot of market cap lost today. Dont kid yourself ET will be looking for ways to make that loss up.
 








I’m not a believer that the new version of Keytruda will be the savior. Yes, injection is easier than infusion, but if each is equal in effectiveness, why would an insurance company shell out more money for our brand name? It reminds me of Schering—Claritin (little to no side effects) was going off patent so we came up with Clarinex (even fewer side effects). Complete bomb, why pay for fewer than ‘little to no side effects.’ That seemed to be a big impetus towards the merger with Merck. Wondering if history is repeating itself.
 




its going to get bad this year, more budget cuts coming soon. At least other company are announcing cuts to budget, people. Merck is trying to do it in the shadows, little by little to “protect their reputation”
 


anonymous said:
its going to get bad this year, more budget cuts coming soon. At least other company are announcing cuts to budget, people. Merck is trying to do it in the shadows, little by little to “protect their reputation”
Click to expand...
Yup. This isn’t the same company anymore. They have zero integrity’. What they’re doing to their employees is absolutely awful. I just want to know how they sleep at night
 




Ominous feelings on the horizon...October call to sit by your phone in December and learn your fate.
So many unknowns about product launches, patent expirations, raising hands (if even an option).
 


anonymous said:
Ominous feelings on the horizon...October call to sit by your phone in December and learn your fate.
So many unknowns about product launches, patent expirations, raising hands (if even an option).
Click to expand...
they want savings this year, wont get that by canning people end of year...I think its coming much sooner that that
 












Honestly, from what I’ve seen I think they are purposefully targeting employees who have been there since original Merck days, that have more extensive benefits and time off. And likely higher salaries. Unlike prior years, they aren’t looking to retain high performers. They’re looking at $$$ only.

Mid level management more at risk.

At this point I don’t even know if it’s better to be laid off and get the benefits, or wait and suffer through the added work and chaos, just to potentially be part of a future round where less might be available.
 



Write your reply...
Top Bottom
Back
Quote